Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

Advanced Medical Solutions Group plc

Healthcare GB AMS

199.4GBX
-(-%)

Last update at 2026-03-10T17:09:00Z

Day Range

197.22205.00
LowHigh

52 Week Range

164.75248.50
LowHigh

Fundamentals

  • Previous Close 199.40
  • Market Cap434.93M
  • Volume737109
  • P/E Ratio50.25
  • Dividend Yield1.33%
  • EBITDA33.66M
  • Revenue TTM220.30M
  • Revenue Per Share TTM1.03
  • Gross Profit TTM 114.98M
  • Diluted EPS TTM0.04

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax 9.82M 21.16M 25.91M 21.98M 10.09M
Minority interest -0.04800M 0.00000M - - -
Net income 7.09M 15.89M 20.41M 17.48M 8.58M
Selling general administrative 69.03M 50.67M 47.38M 36.97M 33.66M
Selling and marketing expenses 2.35M 1.52M 1.63M 1.48M 1.07M
Gross profit 82.77M 70.14M 73.42M 61.07M 46.04M
Reconciled depreciation 16.30M 10.79M 8.84M 8.85M 6.83M
Ebit 13.38M 20.61M 24.89M 23.00M 10.73M
Ebitda 29.68M 31.40M 35.42M 31.93M 18.62M
Depreciation and amortization 16.30M 10.79M 10.54M 8.93M 7.89M
Non operating income net other - - - - -
Operating income 10.45M 18.88M 24.89M 23.00M 10.73M
Other operating expenses 167.07M 107.33M 99.44M 85.60M 75.23M
Interest expense 3.56M 0.38M 0.67M 1.10M 0.86M
Tax provision 2.68M 5.27M 5.50M 4.50M 1.50M
Interest income 1.29M 2.47M 1.69M 0.08M 0.22M
Net interest income -2.26400M 2.09M 1.02M -1.01400M -0.64100M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 2.68M 5.27M 5.50M 4.50M 1.50M
Total revenue 177.52M 126.21M 124.33M 108.60M 86.80M
Total operating expenses 81.40M 51.26M 48.53M 38.07M 34.48M
Cost of revenue 84.90M 56.07M 50.91M 47.53M 40.76M
Total other income expense net -0.63100M 2.27M 1.02M -1.01400M -0.64100M
Discontinued operations - - - - -
Net income from continuing ops 7.14M 15.89M 20.41M 17.48M 8.58M
Net income applicable to common shares - - 20.41M 17.48M 8.58M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 389.00M 289.17M 281.09M 249.51M 238.56M
Intangible assets 97.41M 55.86M 48.37M 40.96M 42.04M
Earning assets - - - - -
Other current assets 0.30M 3.83M 21.74M 22.71M 22.32M
Total liab 147.48M 44.97M 44.47M 36.83M 36.34M
Total stockholder equity 240.78M 244.20M 236.62M 212.68M 202.21M
Deferred long term liab - - - 10.48M 7.37M
Other current liab -1.04600M 11.86M 0.95M 0.90M 0.32M
Common stock 10.89M 10.87M 10.84M 10.80M 10.77M
Capital stock 10.89M 10.87M 10.84M 10.80M 10.77M
Retained earnings 180.47M 178.53M 167.42M 151.35M 137.72M
Other liab - - 13.10M 11.12M 11.77M
Good will 116.88M 80.44M 70.86M 66.03M 68.91M
Other assets 0.00000M - 0.94M 10.58M 7.73M
Cash 17.04M 60.16M 82.26M 72.97M 53.83M
Cash and equivalents - - - - -
Total current liabilities 44.33M 21.58M 22.68M 17.01M 14.71M
Current deferred revenue - -1.16400M - - -
Net debt 72.61M -51.02300M -72.51200M -63.10500M -42.70800M
Short term debt 11.60M 2.33M 1.06M 1.15M 1.26M
Short long term debt 5.42M 0.00000M - - -
Short long term debt total 89.65M 9.14M 9.75M 9.86M 11.12M
Other stockholder equity 32.18M 32.13M 58.36M 50.52M 53.72M
Property plant equipment - - 29.02M 27.44M 30.06M
Total current assets 126.28M 122.32M 131.91M 114.97M 97.17M
Long term investments - - - - -
Net tangible assets - - 117.39M 116.16M 98.63M
Short term investments - - - - -
Net receivables 53.68M 22.29M 21.55M 22.71M 19.50M
Long term debt 67.43M 0.00000M - - 0.00000M
Inventory 55.26M 36.05M 27.91M 19.30M 21.02M
Accounts payable 33.78M 6.23M 20.67M 14.96M 13.14M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 17.23M 22.68M - - -
Additional paid in capital - - - - -
Common stock total equity - - - - 10.77M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.50M 0.59M 0.94M 0.10M 0.36M
Deferred long term asset charges - - - - -
Non current assets total 262.72M 166.85M 149.18M 134.54M 141.38M
Capital lease obligations 13.71M 9.14M 9.75M 9.86M 11.12M
Long term debt total - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments -67.14900M -20.26500M -11.87900M -6.32600M -26.77100M
Change to liabilities - - 1.71M 2.10M -2.29200M
Total cashflows from investing activities -67.14900M -20.26500M -11.87900M -6.32600M -26.77100M
Net borrowings 17.26M -0.48000M -1.62600M -1.28100M -1.81400M
Total cash from financing activities 5.48M -13.61800M -6.32100M -5.10500M -5.82400M
Change to operating activities - - - - -
Net income 7.09M 15.89M 24.89M 23.00M 10.73M
Change in cash -43.12100M -22.10200M 9.30M 19.14M -10.92200M
Begin period cash flow 60.16M 82.26M 72.97M 53.83M 64.75M
End period cash flow 17.04M 60.16M 82.26M 72.97M 53.83M
Total cash from operating activities 19.49M 12.35M 26.88M 31.02M 21.51M
Issuance of capital stock 0.01M 0.18M 0.66M 1.09M 0.60M
Depreciation 16.30M 10.79M 8.84M 8.85M 6.83M
Other cashflows from investing activities 1.23M -3.79300M 0.82M 0.08M 0.28M
Dividends paid 5.20M 4.78M 4.34M 3.85M 3.34M
Change to inventory -0.00200M -8.06400M -7.08700M 0.94M -1.89200M
Change to account receivables -10.38400M -2.51500M -0.59600M -1.76900M 10.26M
Sale purchase of stock 0.00000M -6.71000M -0.39200M -0.36600M -0.54200M
Other cashflows from financing activities -6.59400M -1.83400M -1.91200M -1.61500M -1.34300M
Change to netincome - - 3.60M 3.42M 0.02M
Capital expenditures 4.06M 9.85M 9.96M 6.46M 5.26M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -6.06800M -15.82800M -5.97200M 1.28M 6.08M
Stock based compensation 3.09M 2.92M 2.44M 1.98M 1.61M
Other non cash items 2.16M -1.42000M -3.32400M -4.07700M -3.74000M
Free cash flow 12.67M 2.50M 16.91M 24.56M 16.25M

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (GBX) Price (GBX) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AMS
Advanced Medical Solutions Group plc		 - -% 199.40 50.25 17.86 1.97 1.78 2.36 13.12
CTEC
ConvaTec Group PLC		 - -% 242.80 40.37 16.18 1.94 4.09 3.14 14.84
TSTL
Tristel		 - -% 380.00 51.11 37.04 6.08 7.11 5.94 27.03
SPEC
Inspecs Group plc		 - -% 83.00 - 12.29 0.42 0.80 0.60 9.42
BVC
Batm Advanced Communications Ltd		 0.35 2.39% 15.00 - - 0.45 0.71 0.45 11.26

Reports Covered

Stock Research & News

View All

Profile

Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. The company operates in two segments, Surgical and Woundcare. It offers surgical products, such as tissue adhesives, sutures, haemostats, internal fixation devices, infection control, and internal sealants under LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, and Seal-G, Vitalitec, and ActivHeal brand names. The company provides wound care dressings, including silver alginates, alginates, and foams through its ActivHeal brand, as well as under white label. Advanced Medical Solutions Group plc was founded in 1991 and is headquartered in Winsford, the United Kingdom.

Advanced Medical Solutions Group plc

Premier Park, Winsford, United Kingdom, CW7 3RT

Key Executives

Name Title Year Born
Mr. Andrew Christopher Meredith BSc (Hons) CEO & Exec. Director 1967
Mr. Edward Johnson ACA CFO & Exec. Director 1972
Mr. Alan Richardson Chief Operations Officer NA
Ms. Cathy Tomlinson Group HR Director NA
Mr. Brian Dowd Head of US Commercial Team NA
Mr. Owen Bromley Company Sec. NA
Mr. Andrew Christopher Meredith BSc (Hons) CEO & Executive Director 1966
Mr. Edward Johnson ACA CFO, ESG Lead & Executive Director 1972
Mr. Michael Edward King Investor Relations Manager NA
Simon Swain Head of Legal NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.